Miguel Garcia

Miguel Garcia is a prominent figure in the field of precision medicine, having a background in Pharmaceutical Sciences, Business Administration, and a Doctor of Philosophy degree from prestigious institutions like Harvard Business School and the University of Lisbon.

His educational journey includes studying Accelerating Innovation in Precision Medicine at Harvard Business School, earning an MBA from Universidade Católica Portuguesa, and specializing in Pharmaceutical Sciences at Faculdade de Farmácia da Universidade de Lisboa.

Miguel Garcia's extensive academic qualifications culminated in a Doctor of Philosophy degree from the Faculty of Pharmacy of the University of Lisbon, showcasing his dedication to advancing knowledge and expertise in the pharmaceutical field.

Professionally, Miguel Garcia serves as the CEO of TechnoPhage, SA, where his leadership skills and strategic vision drive the company's success in the ever-evolving landscape of precision medicine.

With a rich professional background, Miguel Garcia has also contributed to the industry as a Board Member at Vector B2B - Drug Development, leveraging his diverse expertise to make significant contributions to the pharmaceutical sector.

His academic prowess is further demonstrated by his past role as an Associate Professor at Egas Moniz University, where he shared his knowledge and passion for pharmaceutical sciences with aspiring professionals.

Miguel Garcia's multifaceted experience in academia and business positions him as a thought leader in precision medicine, with a unique blend of theoretical expertise and practical industry insights.

His leadership at TechnoPhage, SA, combined with his educational background and previous roles, underscores Miguel Garcia's commitment to driving innovation and advancements in the field of precision medicine.